Resilient Supply Chains for Global Health.
Master pharmaceutical supply chain optimisation and digital transformation to ensure life-saving products reach those who need them most.
The 2026 life sciences ecosystem is defined by a rapid convergence of biology and advanced computation. NCSGX navigates this complexity by providing life sciences consulting services that integrate AI-driven drug discovery with robust regulatory frameworks. As the industry shifts toward decentralised trials and personalised medicine, medical device engineering must now account for real-time data interoperability and heightened cybersecurity standards.
By optimising the pharmaceutical supply chain to meet 2026 DSCSA serialisation mandates, NCSGX ensures operational continuity. Leveraging clinical data analytics, the organisation transforms fragmented trial data into the evidence required for accelerated global market access.
Scalable digital transformation in life sciences and biotech
Innovation in the current regulatory environment requires more than technical expertise; it demands an “Innovation-First” approach to compliance. NCSGX facilitates this by aligning medical device engineering with the latest FDA Quality Management System Regulations (QMSR). Â
Beyond hardware, the focus on digital transformation in life sciences empowers organisations to adopt AI-powered pharmacovigilance and automated safety monitoring. NCSGX bridges the gap between laboratory results and patient outcomes by implementing secure, scalable data infrastructures.
Integrated Services for Scalable Growth
Our service portfolio is designed to support transformation across strategy, operations, and technology.
Why NCSGX for Health Care Providers & Life Sciences
Therapeutic Precision
Modern care delivery is shifting toward personalised medicine and Ambulatory Surgery Centres (ASCs).
Operational Agility
With the Medicare Drug Price Negotiation Program affecting revenue structures, operational efficiency is no longer optional.
Clinical Alignment
Success in 2026 is defined by the proximity of science to execution. NCSGX ensures that clinical data analytics are not siloed, but integrated into the commercial roadmap.
Global recognition for life sciences excellence
Council 2022
Agency
Company in USA 2023
Validated technologies for clinical data analytics
NCSGX: A recognized leader in the 2026 Life Sciences Index
Meet Our Senior Management Team

Hitesh Shah (CA, CMA)
CEO – Navkar Group

Aagam Shah (CA)
CEO – NCSGX

Aesha Shah (CA, CPA)
AVP – NCSGX Australia – Finance

Aayushi Shah (CA)
AVP – NCSGX – Marketing

Aneri Shah
AVP – NCSGX – Mortgage

Bijal Bodiwala (CA)
AVP – NCSGX Australia – Finance & Bookkeeping

Utsavi Bhatia
AVP – NCSGX – Paraplanning
Partner with Us for Comprehensive Business & Technology Services
We’re here to help you evaluate your needs and determine how our business consulting, management consulting, and technology‑enabled services can support your goals.
Whether you’re exploring operational optimisation, shared services, IT support, or enterprise transformation, our experts are ready to guide you with clarity and confidence.
Your benefits:
- Client-oriented
- Independent
- Competent
- Results-driven
- Problem-solving
- Transparent
What happens next?
We Schedule a call at your convenience
We do a discovery and consulting meeting
We prepare a proposal